entertainment -WSS

entertainment

author：Wikipedia 2025-09-29 13:30:49 - browse：24741

A phone screen displays the webpage of Medicare.gov — coverage from STAT — Adobe

Over the past few weeks, Medicare Advantage insurers demanded that the Biden administration give them higher payment rates for next year. The government’s data on how much people were using health care didn’t match their own data, insurers and lobbyists griped — and therefore they wouldn’t be paid enough to cover those costs.

But the federal government was not persuaded by the industry’s data or lobbying push. The Biden administration and its Medicare agency decided to stick with their proposals from January on Monday, dealing a blow to an insurance industry that has come to rely on Medicare Advantage for a steady stream of profits.

The result: In 2025, right after a new president is elected, Medicare Advantage insurers will have to absorb a slight decrease of 0.2% to the baseline payment rates that insurers receive from the government for enrolling older adults and people with disabilities. The stock prices of the largest Medicare Advantage insurers — UnitedHealth, Humana, CVS Health, and Elevance Health — all fell by at least 4% in after-hours trading.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Kristina Burow of ARCH Venture Partners shares her next big bets STAT

WSS

How to fix the rural physician shortage in the U.S.

Scientists grapple with ethics of stem cell research

Readout Newsletter: Ironwood, Pfizer, FogPharma updates

Congress gives doctors Medicare pay bump

Hormonal contraceptives don’t actually treat endometriosis

'Golden Bachelor' Gerry Turner reveals what he wants in a partner and more

leisure time

entertainment

hotspot

Hepatitis C has a cure — but many Americans still lack access to it

'Golden Bachelor' Gerry Turner reveals what he wants in a partner and more

Novavax promises a turnaround & Lilly roils the obesity market

This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF

Supreme Court strikes down use of affirmative action

Change Healthcare cyberattack outage could last weeks

Cancer drug shortages should be causing more outrage

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

Psychedelics group wrestles with new pharma identity

Scientists unlock the key to scar

hotspot

Hormonal contraceptives don’t actually treat endometriosis

A new ‘biological computer' targets cancer while sparing healthy cells

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

A woman pleads guilty to fire that kept a Wyoming abortion clinic from opening for a year

How to fix the rural physician shortage in the U.S.

Are infertility treatments 'essential' during the Covid

explore

focus

focus

leisure time